{"created":"2023-06-19T07:25:22.309715+00:00","id":13133,"links":{},"metadata":{"_buckets":{"deposit":"af09ec00-1341-4a4b-bc43-a9768ffee459"},"_deposit":{"created_by":39,"id":"13133","owners":[39],"pid":{"revision_id":0,"type":"depid","value":"13133"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013133","sets":["212:361:364"]},"author_link":["18579","18580"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-04-17","bibliographicIssueDateType":"Issued"},"bibliographic_titles":[{},{"bibliographic_title":"Investigational new drugs","bibliographic_titleLang":"en"}]}]},"item_3_text_4":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_text_value":"10.1007/s10637-018-0603-z"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Unique characteristics of regulatory approval and pivotal studies of orphan anticancer drugs in Japan.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Unique characteristics of regulatory approval and pivotal studies of orphan anticancer drugs in Japan.","subitem_title_language":"en"}]},"item_type_id":"3","owner":"39","path":["364"],"pubdate":{"attribute_name":"公開日","attribute_value":"2018-06-14"},"publish_date":"2018-06-14","publish_status":"0","recid":"13133","relation_version_is_last":true,"title":["Unique characteristics of regulatory approval and pivotal studies of orphan anticancer drugs in Japan."],"weko_creator_id":"39","weko_shared_id":-1},"updated":"2023-06-19T08:59:02.857509+00:00"}